Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001749475-23-000002
Filing Date
2023-04-27
Accepted
2023-04-27 10:54:36
Documents
1
Effectiveness Date
2023-04-27
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6935
  Complete submission text file 0001749475-23-000002.txt   8151
Mailing Address SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP TOU-TOWERS, YITZHAK SADEH 4 TEL AVIV L3 6777520
Business Address SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP TOU-TOWERS, YITZHAK SADEH 4 TEL AVIV L3 6777520 972-3-6845535
Sphera Biotech US Fund, L.P. (Filer) CIK: 0001749475 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-323124 | Film No.: 23853057